These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 16239844

  • 1. Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease.
    Nancey S, Blanvillain E, Parmentier B, Flourié B, Bayet C, Bienvenu J, Fabien N.
    Inflamm Bowel Dis; 2005 Nov; 11(11):986-91. PubMed ID: 16239844
    [Abstract] [Full Text] [Related]

  • 2. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.
    Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, Joossens S, Bossuyt X, Rutgeerts P.
    Gastroenterology; 2003 Jul; 125(1):32-9. PubMed ID: 12851868
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab).
    Garcia-Planella E, Domènech E, Esteve-Comas M, Bernal I, Cabré E, Boix J, Gassull MA.
    Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):351-4. PubMed ID: 12655253
    [Abstract] [Full Text] [Related]

  • 5. Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.
    Kiss LS, Lovasz BD, Golovics PA, Vegh Z, Farkas K, Molnar T, Palatka K, Papp M, Mohas A, Szilagyi BK, Fekete SA, Mandel M, Lakatos PL.
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):135-40. PubMed ID: 23799211
    [Abstract] [Full Text] [Related]

  • 6. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study.
    Atzeni F, Ardizzone S, Sarzi-Puttini P, Colombo E, Maconi G, De Portu S, Carrabba M, Bianchi Porro G.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):453-61. PubMed ID: 16128684
    [Abstract] [Full Text] [Related]

  • 7. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
    De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F.
    Arthritis Rheum; 2005 Jul 01; 52(7):2192-201. PubMed ID: 15986349
    [Abstract] [Full Text] [Related]

  • 8. Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease.
    Elezoglou A, Kafasi N, Kaklamanis PH, Theodossiadis PG, Kapsimali V, Choremi E, Vaiopoulos G, Sfikakis PP.
    Clin Exp Rheumatol; 2007 Jul 01; 25(4 Suppl 45):S65-9. PubMed ID: 17949554
    [Abstract] [Full Text] [Related]

  • 9. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.
    Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM.
    Rheumatol Int; 2006 Jan 01; 26(3):209-14. PubMed ID: 15627197
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction.
    Hoffmann JH, Hartmann M, Enk AH, Hadaschik EN.
    Br J Dermatol; 2011 Dec 01; 165(6):1355-8. PubMed ID: 21801160
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
    Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2005 Mar 01; 64(3):403-7. PubMed ID: 15297281
    [Abstract] [Full Text] [Related]

  • 14. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F.
    Arthritis Rheum; 2003 Apr 01; 48(4):1015-23. PubMed ID: 12687543
    [Abstract] [Full Text] [Related]

  • 15. Autoimmunity and anti-TNF-alpha agents.
    Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P.
    Ann N Y Acad Sci; 2005 Jun 01; 1051():559-69. PubMed ID: 16126996
    [Abstract] [Full Text] [Related]

  • 16. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.
    Allanore Y, Sellam J, Batteux F, Job Deslandre C, Weill B, Kahan A.
    Clin Exp Rheumatol; 2004 Jun 01; 22(6):756-8. PubMed ID: 15638051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN.
    Arthritis Rheum; 2000 Nov 01; 43(11):2383-90. PubMed ID: 11083258
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.